RECENT PUBLICATIONS
2022
Biondi MJ, Hirode G, Capraru C, Vanderhoff A, Karkada J, Wolfson-Stofko B, Smookler D, Friedman SM, Bates K, Mazzulli T, Juan JV. (2022) Birth cohort hepatitis C antibody prevalence in real-world screening settings in Ontario. Canadian Liver Journal:e20210036. doi: 10.3138/canlivj-2021-0036
Varriano B, Porplycia D, & Friedman SM. (2022). Unhelmeted injured cyclists in a Canadian emergency department: cycling behavior and attitudes towards helmet use. INQUIRY: The Journal of Health Care Organization, Provision, and Financing, 59, doi: 10.1177/00469580221083276
Bryan JM, Alavian S, Giffin D, LeBlanc C, Liu J, Phalpher P, Shelton D, Morris J, & Lim R. (2022). CAEP 2021 Academic Symposium: recommendations for addressing racism and colonialism in emergency medicine. Canadian Journal of Emergency Medicine, 1-7, doi: 10.1007/s43678-021-00244-2
Mastoras G, Farooki N, Willinsky J, Dharamsi A, Somers A, Gray A, Yaphe J, Dalseg T, & O’Connor E. (2022). Rapid deployment of a virtual simulation curriculum to prepare for critical care triage during the COVID-19 pandemic. Canadian Journal of Emergency Medicine, 1-8, doi: 10.1007/s43678-022-00280-6
Lexchin, J., Batt, S., Goldberg, D., & Shnier, A. (2022). National patient groups in Canada and their disclosure of relationships with pharmaceutical companies: a cross-sectional study. BMJ open, 12(3), e055287, doi: 10.1136/bmjopen-2021-055287
Beamish IV, Bogoch II, & Carr D. (2022). Delayed inflammatory reaction to dermal fillers after COVID-19 vaccination: a case report. Canadian Journal of Emergency Medicine, 1-3, doi: 10.1007/s43678-022-00289-x
Lexchin J. (2022). Pharmaceutical company payments to healthcare professionals and healthcare organizations in Canada: an observational study. Healthcare Policy. 17(3):42-48, doi: 10.12927/hcpol.2022.26729
Lexchin J. (2022). COVID-19 vaccine task force and conflicts of interest. Healthcare Policy. 17(3):20-27, doi: 10.12927/hcpol.2022.26732
Siu C, Rao S, Hayman K, Hulme J, & Gajaria A. (2022). Exploring the perspectives of healthcare providers that care for non-insured individuals utilizing emergency departments in Toronto. Canadian Journal of Emergency Medicine, 1-5, doi: 10.1007/s43678-022-00263-7
Daniel RC., Atzema CL., Cho DD., Davis PJ., & Costello LL. (2022). Which recommendations are you using? A survey of emergency physician management of paroxysmal atrial fibrillation. CJC Open, doi: 10.1016/j.cjco.2022.01.005
Chartier LB. What's in a name? "Return visits" in the emergency department. Acad Emerg Med. 2022 Mar 17. doi: 10.1111/acem.14485.
Xie EC, Chan K, Khangura JK, Koh JJK, Orkin AM, Sheikh H, Hayman K, Gupta S, Kumar T, Hulme J, Mrochuk M, & Dong K. (2022). CAEP position statement on improving emergency care for persons experiencing homelessness: executive summary. Canadian Journal of Emergency Medicine, 1-7
Meshkat, N, Fremes E, Burke-Bajaj J, Kebede S, & Hunchak C. (2022). Perceptions and reflections of early graduates of the first emergency medicine residency program in Ethiopia: A qualitative study. African Journal of Emergency Medicine, 12(1), 7-11. doi: 10.1016/j.afjem.2021.09.004
Chartier LB, Masood S, Choi J, McGovern B, Casey S, Friedman SM, Porplycia D, Tosoni S, Sabbah S. (2022). A blueprint for building an emergency department quality improvement and patient safety committee. Can J Emerg Med. doi: 10.1007/s43678-021-00252-2
Morrow RL, Mintzes B, Souverein PC, De Bruin ML, Roughead EE, Lexchin J, ... & Dormuth CR. (2022). Influence of drug safety advisories on drug utilisation: an international interrupted time series and meta-analysis. BMJ Quality & Safety. doi: 10.1136/bmjqs-2021-013910
2021
van Lettow M, Tippett Barr BA, van Oosterhout JJ, Schouten E, Jahn A, Kalua T, ... & Landes M. (2021). The National Evaluation of Malawi’s PMTCT Program (NEMAPP) study: 24‐month HIV‐exposed infant outcomes from a prospective cohort study. HIV medicine. doi: 10.1111/hiv.13209
Puchalski Ritchie LM, Kip EC, Mundeva H, van Lettow M, Makwakwa A, Straus SE, Hamid JS, Zwarenstein M, Schull MJ, Chan AK, Martiniuk A, van Schoor V. (2021). Process evaluation of an implementation strategy to support uptake of a tuberculosis treatment adherence intervention to improve TB care and outcomes in Malawi. BMJ Open, 11(7), e048499. doi: 10.1136/bmjopen-2020-048499.
Lexchin J. (2021). Controversial Alzheimer's drug highlights concerns about Health Canada approval process. The Conversation. July 28th, 2021.
Hossain MY, Azhar U, To Y, Choi J, Zaman L. (2021). Automated Escalation and Incident Management in Healthcare During Mass Casualties and Pandemic Events. International Conference on Human-Computer Interaction. pp.68-85. doi: 10.1007/978-3-030-77820-0_6
Lexchin J. (2021). Time to market for drugs approved in Canada between 2014 and 2018: an observational study. BMJ Open, 11(7), e047557. doi: 10.1136/bmjopen-2020-047557
McLaren JTT, Taher AK, Chartier LB. (2021). Flattening the other curve: Reducing emergency department STEMI delays during the COVID-19 pandemic. American Journal of Emergency Medicine, 49, 367-372. doi: 10.1016/j.ajem.2021.06.057
El-Baba M, Corbett K, Dillon K, & Heslop C. (2021). Medical Student POCUS Peer-to-Peer Teaching: Ready for Mainstream. International Journal of Medical Students, 9(1), 11-14. doi: 10.5195/ijms.2021.700.
Gorfinkel I & Lexchin J. CMAJ May 31, 2021 193 (22) E808; doi: 10.1503/cmaj.78920
Lee DD, Jung H, Lou W, Rauchwerger D, Chartier LB, Masood S, Sathiaseelan S, & Taher A. K. (2021). The Impact of COVID-19 on a Large, Canadian Community Emergency Department. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health. doi: 10.5811/westjem.2021.1.50123
Kazevman G, Mercado M, Hulme J, Somers A. Prescribing Phones to Address Health Equity Needs in the COVID-19 Era: The PHONE-CONNECT Program. J Med Internet Res 2021;23(4):e23914. doi: 10.2196/23914
Lexchin J. Formula choices in infants with cow’s milk allergy. Canadian Family Physcian 2021;67:318-319. doi: 10.46747/cfp.6705318_1
Bryan JM, Beyene T, Kebede S, Kaufman A, Jiru T, Maskalyk J, Landes M, McKnight A, Fremes E, Cheung E; Toronto Addis Ababa Academic Collaboration in Emergency Medicine. Maintaining a global health partnership during the COVID-19 pandemic: a road map from the Toronto Addis Ababa Academic Collaboration in Emergency Medicine. CJEM. 2021 Mar;23(2):242-244. doi: 10.1007/s43678-021-00083-1.
Lexchin J. Canada is virtue signalling while waffling on global access to COVID-19 vaccines. The Conversation May 11, 2021.
Ben-Yakov M, James V, Slomovic B. A Young Patient With Hives and Chest Pain. JAMA Cardiol. Published online April 21, 2021. doi: 10.1001/jamacardio.2021.0749
Wiercigroch D, Hoyeck P, Sheikh H, & Hulme J. (2021). A qualitative examination of the current management of opioid use disorder and barriers to prescribing buprenorphine in a Canadian emergency department. BMC Emergency Medicine, 21(1), 1-9. doi: 10.1186/s12873-021-00443-1
Chopra AS, Goodman DA. & Carr D. Don’t look up, a rare but important cause of syncope: Eagle syndrome. Can J Emerg Med (2021). doi: 10.1007/s43678-021-00140-9.
Sheppard G, Pham C, Nowacki A, Bischoff T, & Snider C. (2021). Towards gender equity in emergency medicine: a position statement from the CAEP Women in Emergency Medicine committee. Canadian Journal of Emergency Medicine, 1-5. doi: 10.1007/s43678-021-00114-x.
Lexchin J & Fugh-Berman A. A Ray of Sunshine: Transparency in Physician-Industry Relationships Is Not Enough. J GEN INTERN MED (2021). doi: 10.1007/s11606-021-06657-0
Crickmer M, Lam T, Tavares W, & Meshkat N. (2021). Do PGY-1 residents in Emergency Medicine have enough experiences in resuscitations and other clinical procedures to meet the requirements of a Competence by Design curriculum?. Canadian Medical Education Journal. doi: 10.36834/cmej.70921
Lang R, Benham JL, Atabati O. Hollis A, Tombe T, Shaffer B, Burns KK, MacKean G, Léveillé T, McCormack B, Sheikh H, et al. Attitudes, behaviours and barriers to public health measures for COVID-19: a survey to inform public health messaging. BMC Public Health 21, 765 (2021). doi: 10.1186/s12889-021-10790-0.
Hohl C, Bosychuk R, McRae A, Brooks S, Archambault P, Fok P, Davis P, Landes M...Morrison L. (2021). Development of the Canadian COVID-19 Emergency Department Rapid Reponse Network population-based registry: a methodology study. CMAJ Open, 9 (1). doi: 10.9778/cmajo.20200290.
Landes M, van Lettow M, van Oosterhout J, Schouten E, Auld A, Kalua T, Jahn A, Barr BT. (2021). Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission. Plos One, 16 (3). doi: 10.1371/journal.pone.0248559.
Lexchin J. (2021). Time to marketing of generic drugs after patent expiration in Canada. JAMA Network Open; 4(3): e211143. doi:10.1001/jamanetworkopen.2021.1143
Habibi R, Lexchin J. The COVID-19 vaccination race: why wealthy countries like Canada must do more to help poorer ones get across the finish line. Open Canada. March 9, 2021.
Ben-Yakov M & James V. (2021). Young man with a diffuse rash and red eyes after recovery from COVID-2019. JACEP Open, 2(2). doi:10.1002/emp2.12404.
Lexchin J, Bero LA, Davis C, Gagnon MA. (2021). Commercial influence in health: from transparency to independence. BMJ; 372. doi:/10.1136/bmj.n370.
Ben-Yakov M, Price C, Dharamsi A, Tawadrous D, Choi JM. (2021). Intubator performance and contamination with the use of barrier enclosure devices: Results from a simulated COVID-19 resuscitation. Annals of Work Exposures and Health. doi:10.1093/annweh/wxaa144.
Hobday K, Prata N, Hulme J, and Homer C. Preventing post-partum haemorrhage at home during COVID-19: what are we waiting for? The Lancet Global Health (2021). doi: 10.1016/S2214-109X(21)00003-6
Gupta S, Xie E & Dong K. Treating homelessness as an emergency: learning from the COVID-19 response. Can J Emerg Med 23, 8–9 (2021). doi: 10.1007/s43678-020-00051-1
Lexchin J. The roots of Canada’s COVID-19 vaccine shortage go back decades. The Conversation. February 8, 2021.
Bryan JM, Beyene T, Kebede S, Kaufman A, Jiru T, Maskalyk J, Landes M, McKnight A, Fremes E, Cheung E, Toronto Addis Ababa Academic Collaboration in Emergency Medicine. (2021). Maintaining a global health partnership during the COVID-19 pandemic: a road map from the Toronto Addis Ababa Academic Collaboration in Emergency Medicine, 23(2): 242-244. doi:10.1007/s43678-021-00083-1.
Joel L, Graham J, Herder M, Jefferson T, Lemmens T. (2021). Regulators, Pivotal Clinical Trials, and Drug Regulations in the Age of COVID-19. International Journal of Health Services, 51(1): 5-13. doi:10.1177/0020731420979824
Hohl C, Bosychuk R, McRae A, Brooks S, Archambault P, Fok P, Davis P, Landes M...Morrison L. (2021). Development of the Canadian COVID-19 Emergency Department Rapid Reponse Network population-based registry: a methodology study. CMAJ Open, 9 (1). doi: 10.9778/cmajo.20200290.
Landes M, van Lettow M, van Oosterhout J, Schouten E, Auld A, Kalua T, Jahn A, Barr BT. (2021). Early post-partum viremia predicts long-term non-suppression of viral load in HIV-positive women on ART in Malawi: Implications for the elimination of infant transmission. Plos One, 16 (3). doi: 10.1371/journal.pone.0248559.
Lexchin J. (2021). Time to marketing of generic drugs after patent expiration in Canada. JAMA Network Open; 4(3): e211143. doi:10.1001/jamanetworkopen.2021.1143
Habibi R, Lexchin J. The COVID-19 vaccination race: why wealthy countries like Canada must do more to help poorer ones get across the finish line. Open Canada. March 9, 2021.
Ben-Yakov M & James V. (2021). Young man with a diffuse rash and red eyes after recovery from COVID-2019. JACEP Open, 2(2). doi:10.1002/emp2.12404.
Lexchin J, Bero LA, Davis C, Gagnon MA. (2021). Commercial influence in health: from transparency to independence. BMJ; 372. doi:/10.1136/bmj.n370
Ben-Yakov M, Price C, Dharamsi A, Tawadrous D, Choi JM. (2021). Intubator performance and contamination with the use of barrier enclosure devices: Results from a simulated COVID-19 resuscitation. Annals of Work Exposures and Health. doi:10.1093/annweh/wxaa144.
Benham JL, Lang R, Bruns KK, MacKean G, Leveille T, McCormack B, Sheikh H...Marshall D. (2021). Attitudes, current behaviors and barriers to public health measures that reduce COVID-19 transmission: A qualitative study to inform public health messaging. PloS one, 16(2), e0246941. doi: 10.1371/journal.pone.0246941
2020
Formosa EA, Kishimoto V, Orchanian-Cheff A, Hayman K. (2020). Emergency department interventions for homelessness: a systematic review. Canadian Journal of Emergency Medicine, 1-12. doi:10.1007/s43678-020-00008-4
Kirubarajan A, Khan S, Got T, Yau M, Bryan JM, Friedman SM. Mask shortage during epidemics and pandemics: a scoping review of interventions to overcome limited supply. BMJ Open, 2020; 10(11): 1-25. doi:10.1136/bmjopen-2020-040547
Loutet MG, Zhang J, Varsaneux O, Ferguson A, Hulme J, Stone S, Oldenburger D, Piggott T. (2020). Using Experiential Simulation-Based Learning to Increase Engagement in Global Health Education: an Evaluation of Self-reported Participant Experience. Medical Science Educator. 30, 1245-1253. doi:10.1007/s40670-020-00999-w
Lexchin J. Would pharmacare spell trouble for drug companies? Canadian Centre for Policy Alternatives, August 5, 2020. View article here: http://behindthenumbers.ca/2020/08/05/would-pharmacare-spell-trouble-for-drug-companies/ [behindthenumbers.ca]
Kim D, Jelic T, Woo M, Heslop C, Olszynski P. (2020). Just the Facts: Recommendations on point-of-care ultrasound use and machine infection control during the coronavirus disease 2019 pandemic. CJEM, 22(4), 445-449. doi:10.1017/cem.2020.364
Hoyeck P, Wiercigroch D, Clarke C, Moineddin R, Sheikh H, Hulme J. (2020). Understanding current practice of opioid use disorder management in emergency departments across Canada: A cross-sectional study. CJEM, 22(4), 494-498. doi:10.1017/cem.2020.362
McLaren J, Hayman K, Sheikh H. (2020). CAEP Position Statement – Sick notes for minor illness. CJEM, 22(4), 475-476. doi:10.1017/cem.2020.53
Tawadrous D, Doran S, Davis M. (2020). Use of a smartphone plant identification application in a toxic plant ingestion. CJEM, 22(4), 549-551. doi:10.1017/cem.2020.30
Perry LT, Bhasale A, Fabbri A, Lexchin J, Puil L, Joarder M, Mintzes, B. A descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016. Pharmacoepidemiology and Drug Safety 2020. doi:10.1002/pds.5072
Jarvis J, Lexchin J. WHO’s COVID-19 technology access pool deserves Canada’s support. Policy Options July 14, 2020. Available at: https://policyoptions.irpp.org/magazines/july-2020/whos-covid-19-technology-access-pool-deserves-canadas-support/
Lexchin J. COVID-19: still much to learn. Journal of the Royal Society of Medicine 2020;113(7):244. doi: 10.1177/0141076820932878
Wright JK, Tan DH, Walmsley SL, Hulme J, O’Connor E, Snider C, Cheng I, Chan AK, Borgundvaag B, McLeod S, Gollob MH, Clarke RJ, Dresser L, Haji F, Mazzulli T, Mubareka S, Jüni P, Lee D, Tomlinson G, Kain K, Landes, M. (2020). Protecting Frontline Health Care Workers from COVID-19 with Hydroxychloroquine Pre-exposure Prophylaxis: A structured summary of a study protocol for a randomised placebo-controlled multisite trial in Toronto, Canada. Trials, 21(1), 1-3. doi:10.1186/s13063-020-04577-8
Dharamsi A, Hayman K, Yi S, Chow R, Yee C, Gaylord E, Tawadrous D, Chartier LB, Landes M. (2020). Enhancing departmental preparedness for COVID-19 using rapid cycle in situ simulation. Journal of Hospital Infection. 105(4), 604-607. doi: 10.1016/j.jhin.2020.06.020.
Dion D, Mosleh-Shirazi, Lexchin J. Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study. BMJ Open 2020;10:e034993. doi:10.1136/ bmjopen-2019-034993.
Bhayana R, Wang CD, Menezes RJ, Bartlett ES, Choi J. (2020). Optimising after-hours workflow of computed tomography orders in the emergency department. BMJ open quality, 9(3), e000969. https://doi.org/10.1136/bmjoq-2020-000969
Hansen K, Boyle A, Holroyd B, Phillips G, Benger J, Chartier LB, Lecky F, Vaillancourt S, Cameron P, Waligora G, Kurland L, Truesdale M, on behalf of the IFEM Quality and Safety Special Interest Group (2020). Updated framework on quality and safety in emergency medicine. Emergency Medicine Journal 2020;37:437-442.
Friedman N, Scolnik D, McMurray L, Bryan J. (2020). Acquired methemoglobinemia presenting to the pediatric emergency department: a clinical challenge. Canadian Journal of Emergency Medicine, 1-5.
Barth D, Nemec RM, Cho DD, Slomer A, Cojocari E, Kim K, McLean L, Patriquin CJ. (2020). The practical integration of a hybrid model of ultrasound‐guided peripheral venous access in a large apheresis center. Journal of Clinical Apheresis.
Lexchin J. (2020). "As U.S. buys up remdesivir, ‘vaccine nationalism’ threatens access to COVID-19 treatments". https://theconversation.com/as-u-s-buys-up-remdesivir-vaccine-nationalism-threatens-access-to-covid-19-treatments-141952
Moynihan R, Albarqouni L, Nangla C, Dunn AG, Lexchin J, Bero L. Financial ties between leaders of influential US professional medical associations and industry: cross sectional study. BMJ, 2020; 369:m1505. https://doi.org/10.1136/bmj.m1505
Lexchin J. Key opinion leaders and the control of knowledge. In: Allen DM, Howell JWeds. Groupthink in science: greed, pathological altruism, ideology, competition, and culture. Springer, 2020; 143-152.
James R, Lexchin J. After COVID-19’s tragic roll, Canada must improve quality of life in long-term care homes. The Conversation. June 7, 2020. Available at: https://theconversation.com/after-covid-19s-tragic-toll-canada-must-improve-quality-of-life-in-long-term-care-homes-139763
Elder K, Turner KA, Cosgrove L, Lexchin J, Shnier A, Moore A, Straus S, Thombs BD. Reporting of financial conflicts of interest by Canadian clinical practice guideline producers: a descriptive study. CMAJ, 2020; 192:E617-E625. doi:https://doi.org/10.1503/cmaj.191737
Sanford S, Schwartz B, Khan Y. The role of tacit knowledge in communication and decision-making during emerging public health incidents. International Journal of Disaster Risk Reduction, 2020; 101681. doi:https://doi.org/10.1016/j.ijdrr.2020.101681
Aubry T, Bloch G, Brcic V, Saad A, Magwood O, Abdalla T, Alkhateeb Q, Xie E, Mathew C, Hannigan T, Costello C, Thavorn K, Stergiopoulos V, Tugwell P, Pottie E. Effectiveness of permanent supportive housing and income assistance interventions for homeless individuals in high-income countries: a systematic review. The Lancet Public Health, 2020; 5(6): e342-e360. doi:https://doi.org/10.1016/S2468-2667(20)30055-4
Lexchin J. Drug Promotion in India Since 2000: Problems Remain. International Journal of Health Services, 2020; doi:https://doi.org/10.1177/0020731420932109
Lexchin J. Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study. International Journal of Health Policy and Management, 2020; doi:10.34172/ijhpm.2020.100
Lexchin J. Health Canada's Proposal to Accelerate New Drug Reviews. Healthcare Policy, 2020; 15(4), 26-34. doi:10.12927/hcpol.2020.26227
Friedman SM, Porplycia D. STAR-EM: An innovative summer research program for medical students. CJEM, 2020; 1-4. doi:10.1017/cem.2020.366
Wiercigroch D, Ben-Yakov M, Friedman SM. Regional anesthesia in Canadian emergency departments: emergency physician practices, perspectives and barriers to use. CJEM, 2020; 1-5. doi:10.1017/cem.2020.51
Turner K, Carboni-Jiménez A, Benea C, Katharine E, Levis B, Boruff J, Roseman M, Bero L, Lexchin J, Turner EH, Benedetti A, Thombs BD. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study. BMJ Open, 2020; 10(5), e035633. doi:10.1136/bmjopen-2019-035633
Woolner V, Ahluwalia R, Lum H, Beane K, Avelino J, Chartier LB. Improving timely analgesia administration for musculoskeletal pain in the emergency department. BMJ Open Quality, 2020; 9(1), e000797. doi:10.1136/bmjoq-2019-000797
Ostrow O, Shim A, Azmat S, Zelinka A, Masood S, Chartier, LB. Pediatric Emergency Department Return Visits: An Innovative and Systematic Approach to Promote Quality Improvement and Patient Safety. Pediatr Emerg Care, 2020; [Epub ahead of print]. PMID: 31977769. doi:10.1097/PEC.0000000000001999
Thull-Freedman, J, Mondoux, S, Stang, A, Chartier LB. Going to the COVID-19 Gemba: Using observation and high reliability strategies to achieve safety in a time of crisis. CJEM, 2020; 1-4. doi:10.1017/cem.2020.380
Mondoux S, Thull-Freedman J, Dowling S, Gardner K, Taher A, Gupta R, Trivedi S, Lindsay H, Finlayson A, Berthelot S, Kwok E, Chartier LB. Quality improvement in the time of COVID-19 – a change strategy well suited to pandemic response. CJEM, 2020; 1-4. doi:10.1017/cem.2020.386
Nolan B, Chartier LB, Verbeek P, Huyer D, Mazurik L. Recommendations for emergency departments receiving patients with vital signs absent from paramedics during COVID-19. CJEM, 2020; 1-5. doi:10.1017/cem.2020.389
Lexchin J. Affordable Biologics for All. JAMA Netw Open. 2020;3(4):e204753. doi:10.1001/jamanetworkopen.2020.4753
Hendin A, La Rivière, CG, Williscroft DM, O'Connor E, Hughes J, Fischer LM. End-of-life care in the Emergency Department for the patient imminently dying of a highly transmissible acute respiratory infection (such as COVID-19). CJEM, 2020; 1-5. doi:10.1017/cem.2020.352
Lexchin J, Rasmussen N. The rise and fall of the neurotic housewife: patient sex in psychotropic drug advertising to physicians 1946-1990. International Journal of Health Services 2020: DOI: 10.1177/0020731420912999
Benea C, Turner KA, Roseman M, Bero LA, Lexchin J, Turner EH, Thombs BD. Reporting of financial conflicts of interest in meta-analyses of drug trials published in high-impact medical journals: comparison of results from 2017 to 2018 and 2009. Systematic Reviews 2020;9:77
Hobday K, Zwi AB, Homer C, Kirkham R, Hulme J, Wate PZ, Prata N. Misoprostol for the prevention of post-partum haemorrhage in Mozambique: an analysis of the interface between human rights, maternal health and development. BMC International Health and Human Rights. 2020; 20(1):1-3.
Lexchin J, Mintzes B. Opioid marketing to Canadian doctors hyped benefits, downplayed harms. The Conversation. March 10, 2020. Available at: https://theconversation.com/opioid-marketing-to-canadian-doctors-hyped-benefits-downplayed-harms-132732
Lexchin J. Canada’s coronavirus aid package guards against drug shortages with compulsory licensing. The Conversation. March 30, 2020. Available at: https://theconversation.com/canadas-coronavirus-aid-package-guards-against-drug-shortages-with-compulsory-licensing-134974